Cargando…

Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival

BACKGROUND: Aberrant DNA methylation at imprinted loci is an important molecular mechanism contributing to several developmental and pathological disorders including cancer. However, knowledge about imprinting defects due to DNA methylation changes is relatively limited in hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Sumadi Lukman, Krech, Till, Hasemeier, Britta, Schipper, Elisa, Schweitzer, Nora, Vogel, Arndt, Kreipe, Hans, Lehmann, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606497/
https://www.ncbi.nlm.nih.gov/pubmed/26473022
http://dx.doi.org/10.1186/s13148-015-0145-6
_version_ 1782395362390048768
author Anwar, Sumadi Lukman
Krech, Till
Hasemeier, Britta
Schipper, Elisa
Schweitzer, Nora
Vogel, Arndt
Kreipe, Hans
Lehmann, Ulrich
author_facet Anwar, Sumadi Lukman
Krech, Till
Hasemeier, Britta
Schipper, Elisa
Schweitzer, Nora
Vogel, Arndt
Kreipe, Hans
Lehmann, Ulrich
author_sort Anwar, Sumadi Lukman
collection PubMed
description BACKGROUND: Aberrant DNA methylation at imprinted loci is an important molecular mechanism contributing to several developmental and pathological disorders including cancer. However, knowledge about imprinting defects due to DNA methylation changes is relatively limited in hepatocellular carcinoma (HCC), the third leading cause of cancer death worldwide. Therefore, comprehensive quantitative DNA methylation analysis at imprinted loci showing ~50 % methylation in healthy liver tissues was performed in primary HCC specimens and the peritumoural liver tissues. RESULTS: We found frequent and extensive DNA methylation aberrations at many imprinted loci in HCC. Unsupervised cluster analysis of DNA methylation patterns at imprinted loci revealed subgroups of HCCs with moderate and severe loss of methylation. Hypomethylation at imprinted loci correlated significantly with poor overall survival (log-rank test, p = 0.02). Demethylation at imprinted loci was accompanied by loss of methylation at LINE-1, a commonly used marker for global DNA methylation levels (p < 0.001). In addition, we found that loss of methylation at imprinted loci correlated with the presence of a CTNNB1 mutation (Fisher’s exact test p = 0.03). Re-analysis of publically available genome-wide methylation data sets confirmed our findings. The analysis of benign liver tumours (hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH)), the corresponding adjacent liver tissues, and healthy liver tissues showed that aberrant DNA methylation at imprinted loci is specific for HCC. CONCLUSIONS: Our analyses demonstrate frequent and widespread DNA methylation aberrations at imprinted loci in human HCC and identified a hypomethylated subgroup of patients with shorter overall survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0145-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4606497
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46064972015-10-16 Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival Anwar, Sumadi Lukman Krech, Till Hasemeier, Britta Schipper, Elisa Schweitzer, Nora Vogel, Arndt Kreipe, Hans Lehmann, Ulrich Clin Epigenetics Research BACKGROUND: Aberrant DNA methylation at imprinted loci is an important molecular mechanism contributing to several developmental and pathological disorders including cancer. However, knowledge about imprinting defects due to DNA methylation changes is relatively limited in hepatocellular carcinoma (HCC), the third leading cause of cancer death worldwide. Therefore, comprehensive quantitative DNA methylation analysis at imprinted loci showing ~50 % methylation in healthy liver tissues was performed in primary HCC specimens and the peritumoural liver tissues. RESULTS: We found frequent and extensive DNA methylation aberrations at many imprinted loci in HCC. Unsupervised cluster analysis of DNA methylation patterns at imprinted loci revealed subgroups of HCCs with moderate and severe loss of methylation. Hypomethylation at imprinted loci correlated significantly with poor overall survival (log-rank test, p = 0.02). Demethylation at imprinted loci was accompanied by loss of methylation at LINE-1, a commonly used marker for global DNA methylation levels (p < 0.001). In addition, we found that loss of methylation at imprinted loci correlated with the presence of a CTNNB1 mutation (Fisher’s exact test p = 0.03). Re-analysis of publically available genome-wide methylation data sets confirmed our findings. The analysis of benign liver tumours (hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH)), the corresponding adjacent liver tissues, and healthy liver tissues showed that aberrant DNA methylation at imprinted loci is specific for HCC. CONCLUSIONS: Our analyses demonstrate frequent and widespread DNA methylation aberrations at imprinted loci in human HCC and identified a hypomethylated subgroup of patients with shorter overall survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0145-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-15 /pmc/articles/PMC4606497/ /pubmed/26473022 http://dx.doi.org/10.1186/s13148-015-0145-6 Text en © Anwar et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Anwar, Sumadi Lukman
Krech, Till
Hasemeier, Britta
Schipper, Elisa
Schweitzer, Nora
Vogel, Arndt
Kreipe, Hans
Lehmann, Ulrich
Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
title Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
title_full Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
title_fullStr Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
title_full_unstemmed Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
title_short Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
title_sort loss of dna methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606497/
https://www.ncbi.nlm.nih.gov/pubmed/26473022
http://dx.doi.org/10.1186/s13148-015-0145-6
work_keys_str_mv AT anwarsumadilukman lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival
AT krechtill lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival
AT hasemeierbritta lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival
AT schipperelisa lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival
AT schweitzernora lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival
AT vogelarndt lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival
AT kreipehans lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival
AT lehmannulrich lossofdnamethylationatimprintedlociisafrequenteventinhepatocellularcarcinomaandidentifiespatientswithshortenedsurvival